Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 4

1(16.7%)

Phase 3

1(16.7%)

6Total

N/A(4)

Phase 4(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07346365Not ApplicableNot Yet Recruiting

Spontaneous Dislocation and Adverse Events of a Prophylactic Pancreatic Stent

Role: collaborator

NCT03563677Not ApplicableCompleted

Dual Guidance Structure for Evaluation of Patients With Unclear Diagnosis in Centers for Rare Diseases

Role: collaborator

NCT03587324Not ApplicableCompleted

Perioperative Aspirin Response in Patients Undergoing Vascular Surgery

Role: lead

NCT01900327Phase 3Terminated

Neoadjuvant Treatment in Resectable Pancreatic Cancer

Role: collaborator

NCT03277625Unknown

Modified Reconstruction for Pancreatic Head Resection

Role: lead

NCT01400100Not ApplicableCompleted

Effects of Intraarterial Octreotide on Pancreatic Texture

Role: lead

NCT01385735Phase 4Unknown

Emotion, Mood and Executive Function in Parkinson's Disease (PD)

Role: lead

All 7 trials loaded